Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > 02269 WUXI BIO > Detailed Quotes

02269 WUXI BIO

Watchlist
69.850
-0.150-0.21%
Trading Session 08/17 15:17 CCT
High
71.450
Open
70.000
Turnover
440.93M
Low
68.700
Pre Close
70.000
Volume
6.31M
Market Cap
297.87B
P/E(TTM)
71.86
52wk High
127.300
Shares
4.26B
P/E(Static)
71.86
52wk Low
40.300
Float Cap
297.87B
Bid/Ask %
0.78%
Historical High
148.000
Shs Float
4.26B
Volume Ratio
0.45
Historical Low
8.333
Dividend TTM
--
Div Yield TTM
--
P/B
7.54
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.15%
Amplitude
3.93%
Avg Price
69.828
Lot Size
500
Float Cap
297.87B
Bid/Ask %
0.78%
Historical High
148.000
Shs Float
4.26B
Volume Ratio
0.45
Historical Low
8.333
Dividend TTM
--
P/B
7.54
Dividend LFY
--
Turnover Ratio
0.15%
Amplitude
3.93%
Avg Price
69.828
Lot Size
500
Price Forecast

No Data

News

Comment

Company Overview More
Yao Ming Biotechnology Co., Ltd. is an investment holding company mainly providing biological agent discovery, development and production services. The company provides one-stop end-to-end biopharmaceutical services through the Integrated Biopharmaceutical contract Research, Development and production Organization (CRDMO) platform. The stage of biopharmaceutical development includes pre-IND (drug discovery, preclinical development), early (phase I and II) clinical development, late (phase III) clinical development and commercial production. The company also provides vaccine end-to-end CRDMO services, including vaccine discovery and development, scale-up commercial production and global distribution. The company has WuXiBody bispecific antibody technology platform, SDArBodY multi-specific antibody technology platform, WuXia cell line development platform, WuXiUP continuous production platform and mRNA vaccine platform. The company mainly operates in China's domestic and overseas markets.
CEO: Ge Li
Market: Hong Kong motherboard
Futu Hot List
HKUSCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top